KDM1A and Merkel cell skin cancer: Two recent studies, including one published in this issue of EMBO Molecular Medicine and the other recently published in Nature Cell Biology, identified LSD1 inhibition as a new therapeutic strategy to treat MCC (Leiendecker et al, 2020; Park et al, 2020).